Technical Analysis for STAB - Statera Biopharma Inc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | Down | Flat |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Expansion Breakdown | Bearish Swing Setup | 0.00% | |
| Jack-in-the-Box Bearish | Bearish Swing Setup | 0.00% | |
| Stochastic Buy Signal | Bullish | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Expansion Breakdown | Bearish Swing Setup | 0.00% | |
| Jack-in-the-Box Bearish | Bearish Swing Setup | 0.00% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Rose Above 20 DMA | about 11 hours ago |
| Rose Above 10 DMA | about 11 hours ago |
| Rose Above Upper Bollinger Band | about 11 hours ago |
| Rose Above Lower Bollinger Band | about 11 hours ago |
| Fell Below Lower Bollinger Band | about 11 hours ago |
Get a Trading Assistant
Statera Biopharma Inc Description
Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within patients a response of antigen-specific killer T-cells and antibodies, thereby activating essential immune defenses against autoimmune, inflammatory, infectious diseases, and cancers. It has clinical programs for Crohn's disease (STAT-201), hematology (Entolimod), pancreatic cancer (STAT-401), and COVID-19 (STAT-205), as well as fibromyalgia and multiple sclerosis. The company was formerly known as Cytocom, Inc. and changed its name to Statera Biopharma, Inc. in September 2021. Statera Biopharma, Inc. is based in Fort Collins, Colorado.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Medical Specialties Biopharmaceutical Clinical Medicine Infectious Diseases Cancers Immunology Autoimmune Diseases Antibodies Immunotherapy Immunotherapies Cancer Treatments Multiple Sclerosis Fibromyalgia Crohn's Disease Pancreatic Cancer Virotherapy Inflammatory Autoimmunity
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.0485 |
| 52 Week Low | 0.0003 |
| Average Volume | 37,780 |
| 200-Day Moving Average | 0.0000 |
| 50-Day Moving Average | 0.0050 |
| 20-Day Moving Average | 0.0003 |
| 10-Day Moving Average | 0.0003 |
| Average True Range | 0.0007 |
| RSI (14) | 50.00 |
| ADX | 5.57 |
| +DI | 23.8095 |
| -DI | 22.6190 |
| Chandelier Exit (Long, 3 ATRs) | -0.0018 |
| Chandelier Exit (Short, 3 ATRs) | 0.0024 |
| Upper Bollinger Bands | 0.0003 |
| Lower Bollinger Band | 0.0003 |
| Percent B (%b) | 0.0 |
| BandWidth | 0.0000 |
| MACD Line | -0.0010 |
| MACD Signal Line | -0.0016 |
| MACD Histogram | 0.0005 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.0003 | ||||
| Resistance 3 (R3) | 0.0003 | 0.0003 | 0.0003 | ||
| Resistance 2 (R2) | 0.0003 | 0.0003 | 0.0003 | 0.0003 | |
| Resistance 1 (R1) | 0.0003 | 0.0003 | 0.0003 | 0.0003 | 0.0003 |
| Pivot Point | 0.0003 | 0.0003 | 0.0003 | 0.0003 | 0.0003 |
| Support 1 (S1) | 0.0003 | 0.0003 | 0.0003 | 0.0003 | 0.0003 |
| Support 2 (S2) | 0.0003 | 0.0003 | 0.0003 | 0.0003 | |
| Support 3 (S3) | 0.0003 | 0.0003 | 0.0003 | ||
| Support 4 (S4) | 0.0003 |
